INFINITI FLU A-sH1N1
-
The INFINITI FLU A-sH1N1 is CE Marked.
-
The INFINITI FLU A-sH1N1 is designed to detect influenza A and differentiate between influenza A and influenza A subtype Swine H1N1 (2009).
-
The INFINITI FLU A-sH1N1 utilizes the FLU A-sH1N1 Intellipac, FLU A-sH1N1 Amp Mix and the FLU A-sH1N1 BioFilmChip Microarray.
-
The INFINITI FLU A-sH1N1 is automated by the INFINITI Analyzer.
Analytes Detected:
- Influenza
- A-Swine H1N1 (2009)
Features:
-
Simultaneous multiplexed determination of influenza A subtype Swine H1N1 (2009)
-
Rapid turnaround time enhances workflow efficiency
-
Load & Go automated on the INFINITI/INFINITI PLUS Analyzer.
-
Replicate determinations on a single BioFilmChip Microarray ensures quality results.
Sample Type and Volume:
- Uses nasopharyngeal aspirates (NPA).
- Requires 8 ul of purified RNA/reaction
Clinical Relevance:
- Only 28% of hospitalizations and 17% of children with laboratory-confirmed influenza infections were diagnosed as actually having influenza.
Clinical Utility:
- Rapid respiratory virus diagnosis of inpatients can lead to benefits in several areas: up to 50% reduction in hospital days, 30% reduction in antibiotic use, and 20% reduction in unnecessary diagnostic tests and procedures.
- Will allow:
- public health labs to track multiple viruses with 1 sampling
- monitoring of viral subtypes in the populace
- easy integration to existing workflows
References:
- K.A. Poehling, et.al., The Underrecognized Burden of Influenza in Young Children NEJM, 2006;355:31-40.
- CDC: Disease Surveillance
- Hendrickson, K. J. 2005. Cost-effective use of rapid diagnostic
techniques in the treatment and prevention of viral respiratory infections. Pediatr Ann 34(1) 24-31.